MARATTO

article · Arabian Journal of Chemistry

Antimicrobial activity of biosynthesized Cuo/Se nanocomposite against Helicobacter pylori

Abstract

Recently, nanotechnology has been considered one of most frontiers in scientific sector, which increasingly attracts researchers’ interest due to its variable and valuable applications in all areas. The synthesis of nanoparticles represents a promising era in therapeutic research that may lead to the development of new approaches in pharmaceutical studies. Selenium nanoparticles (SeNPs) share a status of high repute owing to their remarkable therapeutic potential. Biological synthesis of environment-friendly SeNPs using plant extracts has emerged as a beneficial alternative approach to chemical synthesis. In this regard, we have synthesized biogenic PG-SeNPs using pomegranate peels aqueous extract (PPAE) as a stabilizing and reducing agent. The PG-SeNPs were evaluated for their anti-Helicobacter pylori and anti-stomach cancer potential. The PG-SeNPs were efficacious against H. pylori. The PG-SeNPs showed dose-dependent restriction of the growth of H. pylori. The anti-stomach cancer ability of the PG-SeNPs was evaluated against SNU-16 stomach cancer. As evident from the MTT results, PG-SeNPs reduced cell viability in a dose-dependent manner. Briefly, the PG-SeNPs evolved with synergistically emerging attributes that were effective against H. pylori; Moreover, the PG-SeNPs and [email protected] embody intriguing anticancer potential against stomach cancer cells.

Research topics

  • Pomegranate: compositions and health benefits
  • Cynara cardunculus studies
  • Moringa oleifera research and applications

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.arabjc.2023.105095

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.